I think COMy has become really one of the highlights in the field of education in multiple myeloma, and thanks to our wonderful faculty, we are able to deliver a fantastic scientific program, cutting edge, really up to date. So during this 8th COMy that will take place in Paris on May 12 to 14, 2022, it’s going to be hybrid, so you can either be in person there and would love to have you with us, or of course, if for some reason you’re not able to travel, everything will be broadcasted and you’ll be able to follow it...
I think COMy has become really one of the highlights in the field of education in multiple myeloma, and thanks to our wonderful faculty, we are able to deliver a fantastic scientific program, cutting edge, really up to date. So during this 8th COMy that will take place in Paris on May 12 to 14, 2022, it’s going to be hybrid, so you can either be in person there and would love to have you with us, or of course, if for some reason you’re not able to travel, everything will be broadcasted and you’ll be able to follow it.
Going into the details, I’ll give you a few hints about some of the key sessions, things that people really need to follow. For instance, how to assess disease risk. You will hear from Dr Shaji Kumar from the Mayo Clinic, the latest news about the diagnostic criteria and how to perform a state-of-the-art workup. We know that imaging is crucial. Dr. Elena Zamagni will give you, really, the latest recommendation. More and more genomics is taking a crucial role. This is why we are pleased to have Professor Hervé Avet-Loiseau, Professor Jill Corre, Professor Irene Ghobrial, who will tackle the clonality, the role of the transcriptome. This session is really very, very important.